Key Takeaways
- The “Diabetes Blue Table” project highlights Type 2 diabetes prevention and management through lifestyle changes.
- Experts from TEMD, alongside public figures, discuss diabetes risks and the importance of nutrition and physical activity.
- The initiative is supported by Boehringer Ingelheim and launched on World Diabetes Day.
The Turkish Society of Endocrinology and Metabolism (TEMD), in collaboration with Boehringer Ingelheim, has launched the “Diabetes Blue Table” project to raise awareness about diabetes, a major public health issue in Türkiye and globally. This initiative, launched on November 14—World Diabetes Day—aims to educate the public on the prevention and management of Type 2 diabetes through lifestyle changes. With nearly 95% of all diabetes cases globally being Type 2, the project underscores the potential of diet and physical activity in preventing and managing this disease.
The “Diabetes Blue Table” is a four-part digital series featuring a roundtable discussion with TEMD representatives, including Prof. Dr. Ayşe Kubat Üzüm (Vice President) and Prof. Dr. Mine Adaş (Board Member). They are joined by dietitian Elvan Odabaşı, former national volleyball player Neslihan Demir, and chef Şerife Aksoy, who prepares healthy meals suitable for individuals living with diabetes or those aiming to prevent the condition. The blue-themed table setting symbolizes the global symbol of diabetes awareness, drawing attention to the impact of diabetes, which currently affects 415 million people worldwide.
Experts Highlight Diabetes Risks and Lifestyle Solutions
The “Diabetes Blue Table” sessions offer an engaging platform where experts discuss critical topics related to diabetes, such as risk factors, complications, and the importance of a healthy lifestyle. During the discussions, Prof. Dr. Ayşe Kubat Üzüm and Prof. Dr. Mine Adaş emphasize the rising prevalence of diabetes, often referred to as the “silent epidemic.” They explain how Type 2 diabetes, which accounts for most cases, can cause severe organ damage if not managed properly. However, they also highlight that it is largely preventable and manageable with early diagnosis and a holistic approach that includes healthy eating and regular physical activity.
Dietitian Elvan Odabaşı and Neslihan Demir contribute practical tips on incorporating nutrition and exercise into daily routines, aiming to make healthy habits more accessible and achievable. Their insights offer a real-world perspective, demonstrating how small changes in lifestyle can significantly impact long-term health outcomes for those at risk of or currently living with diabetes.
The Growing Impact of Diabetes in Türkiye and Global Projections
Globally, approximately 415 million adults live with diabetes, a number projected to exceed 700 million within the next 25 years if significant preventive measures are not implemented. In Türkiye, the prevalence of diabetes is estimated to be around 15%, according to the International Diabetes Federation and the Turkish Ministry of Health. This figure continues to rise, highlighting the urgent need for public health initiatives like TEMD’s “Diabetes Blue Table.” The series aims to increase awareness and encourage preventive measures through expert insights and accessible educational content.
Boehringer Ingelheim, supporting this initiative, underscores its commitment to enhancing diabetes awareness and prevention. The company has consistently backed efforts aimed at improving public health, especially in areas with unmet medical needs like diabetes. By partnering with TEMD, Boehringer Ingelheim aims to contribute to reducing diabetes rates in Türkiye and promote healthier lifestyles across the country.
The first episode of the “Diabetes Blue Table” series premiered on November 14 through TEMD and Boehringer Ingelheim’s social media platforms, engaging viewers with expert discussions and practical health advice. The episodes, released in four parts, continue to be a valuable resource for individuals seeking to understand and manage diabetes through informed lifestyle choices.
Source: Boehringer Ingelheim, October 15, 2024
This article has been prepared with the assistance of AI and reviewed by an editor. For more details, please refer to our Terms and Conditions. We do not accept any responsibility or liability for the accuracy, content, images, videos, licenses, completeness, legality, or reliability of the information contained in this article. If you have any complaints or copyright issues related to this article, kindly contact the author.
